Preferential decrease in IgG 4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis
暂无分享,去创建一个
B. Dijkmans | W. Lems | M. Nurmohamed | L. Aarden | G. Wolbink | D. Schaardenburg | D. Hamann | M. Vis | W. Bos | R. De | G. M. Bartelds | A. V. D. Horst | Stadt | A. R. Horst